Quantcast

Latest Rafarma Pharmaceuticals Inc. Stories

2014-04-10 08:30:56

MOSCOW, April 10, 2014 /PRNewswire/ -- In response to shareholder inquiries, CEO Dave Anderson offers further comment on the improved financial position of Rafarma: "Due to the overwhelming response to our recent news release regarding the VEBank loan restructuring the company would like to provide some additional details," said Anderson. A key element of the restructuring is a deferment creating significant cost savings--particularly when compounded. Another very significant element...

2014-02-05 08:29:25

MOSCOW, Feb. 5, 2014 /PRNewswire/ -- On February 3, 2014, ZAO Rafarma management met with senior faculty members of the St. Petersburg Academy of Pharmaceutical Chemistry to create a long-term cooperative agreement. Rafarma will work with and be able to recruit from the finest pharmaceutical specialists graduating in Russia, as well as having access to the Academy's innovative pharmaceutical research. The cooperative agreement is borne out of the initiatives outlined in "Pharma...

2014-01-28 12:29:35

MOSCOW, Jan. 28, 2014 /PRNewswire/ -- Rafarma Pharmaceuticals (OTC:RAFA) and St. Petersburg-based Pharmsynthez have opened discussions for Joint Venture Production. At meetings initiated by Governor Oleg Korolev of Lipetsk, Management from Rafarma and Pharmsynthez have agreed in principal to commence a 'joint venture production plan', with the potential to substantially increase revenues for both companies. The agreement is contingent upon a satisfactory technical audit of...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related